DR Congo's Ebola Outbreak Exceeds Previous Epidemic's Case Count
Quick Look
- The Democratic Republic of Congo's latest Ebola outbreak has surpassed the 2018-2020 epidemic's case count, with 3,532 confirmed cases and 1,556 deaths across five provinces.
- It is now the world's second-largest and fastest-spreading Ebola epidemic, complicated by ongoing conflict in the eastern regions.
AI-generated summary
Why It Matters
The current Ebola outbreak in DR Congo has surpassed the 2018-2020 epidemic in total cases, becoming the world's second-largest and fastest-spreading, with 3,532 cases and 1,556 deaths confirmed.
The Democratic Republic of Congo's (DRC) latest Ebola outbreak has surpassed the total number of cases recorded during the country's deadliest epidemic between 2018 and 2020.
That epidemic killed nearly 2,300 people among about 3,500 infections.
Congolese officials said on Friday that in this year's outbreak 3,532 Ebola cases, including 1,556 deaths, have now been confirmed across five provinces.
Second-Largest Ebola Outbreak on Record
The outbreak has grown into the world's second-largest Ebola epidemic.
"It's the fastest-spreading Ebola epidemic that we have ever seen," said Carl Skau, acting executive director of the UN World Food Programme told Reuters.
"The world needs to pay much more attention," he added.
The outbreak has proven unusually deadly, killing five times more people in its first three months than previous Ebola outbreaks had by the same stage, according to the Africa Centres for Disease Control and Prevention.
Only the 2014-16 West Africa outbreak was bigger, with 28,616 cases reported across Guinea, Liberia and Sierra Leone.
According to the World Health Organization (WHO), Ebolais a severe and often fatal disease that spreads from infected animals and through direct contact with the bodily fluids of infected people.
Experimental vaccines raise hope
The outbreak is being caused by the Bundibugyo strain of Ebola, for which no approved vaccine or treatment currently exists.
However, vaccine research is gaining momentum — the WHO has described a vaccine being developed by Singapore-based Hilleman Laboratories as the most promising candidate against the outbreak.
A separate Bundibugyo vaccine is also under development by the University of Oxford. Last week, the first volunteer received a dose as part of an ongoing clinical trial.
Ebola Spreads Amid Conflict and Instability
The outbreak is centred in Ituri province in northeastern DR Congo, near the borders with South Sudan and Uganda.
Health officials say the true scale of the epidemic remains unclear.
Since the outbreak was declared, cases have risen rapidly. Confirmed infections increased from 2,000 on July 15 to more than 3,500 within weeks.
The virus has also spread to four other provinces. These include North Kivu and South Kivu, where large areas are controlled by the Rwanda-backed M23 rebel group.
DR Congo is grappling with ongoing instability in its eastern regions, where conflict involving the M23 rebel group continues despite peace efforts.
What to Watch
AI outlook — possibilities, not facts
Clinical trials for the Bundibugyo vaccine will continue.
Very likely · Within months
Open Questions
- What is the true scale of the epidemic given conflict zones?
- How will experimental vaccines impact the outbreak?






